HeartBeam (BEAT) Cash from Investing Activities (2023 - 2026)
HeartBeam's (BEAT) quarterly Cash from Investing Activities came in at -$249000.0 in Q2 2026, down 113.38% year-over-year from $1.9 million in Q2 2025, and down 1.22% quarter-over-quarter from -$246000.0 in Q1 2026.
Powered by 
Analysis
HeartBeam (BEAT) Cash from Investing Activities (2023 - 2026) Analysis & Trends
HeartBeam (BEAT) has reported Cash from Investing Activities for 4 consecutive years, with -$249000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Investing Activities fell 113.38% year-over-year to -$249000.0 in Q2 2026; TTM through Jun 2026 was $804000.0, a 140.16% increase from a year earlier, with the FY2025 full-year figure at -$600000.0, down 198.51% from the prior year.
- Cash from Investing Activities was -$249000.0 for Q2 2026 at HeartBeam, down from -$246000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $3.8 million in Q3 2023 and troughed at -$3.9 million in Q2 2023.
- A 4-year average of -$129333.3 and a median of -$107500.0 in 2023 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 18710.0% in 2025, down 4172.73% in 2025.
- Over 4 years, Cash from Investing Activities stood at -$112000.0 in 2023, then climbed by 8.04% to -$103000.0 in 2024, then plunged by 303.88% to -$416000.0 in 2025, then surged by 40.14% to -$249000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$249000.0 (Q2 2026), -$246000.0 (Q1 2026), and -$416000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | -383.65 Mn |
| 10 | HeartBeam | 24.23 Mn | 24.23 Mn | - | -249,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -249,000.00 |
| Mar 31, 2026 | -246,000.00 |
| Dec 31, 2025 | -416,000.00 |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 1.86 Mn |
| Mar 31, 2025 | -3.76 Mn |
| Sep 30, 2024 | -103,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Mar 31, 2024 | -88,000.00 |
| Dec 31, 2023 | -112,000.00 |
| Sep 30, 2023 | 3.80 Mn |
| Jun 30, 2023 | -3.94 Mn |